Selected research
Industry Growth & Trends
Global Rare Disease CRO Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Rare Disease CRO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Rare Disease CRO Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Rare Disease CRO Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Rare Disease CRO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Rare Disease CRO Service market include Precision for Medicine, Orphan-Reach, Medpace, Parexel, PPD, Worldwide Clinical Trials, AllStripes, LabCorp and Novotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Rare Disease CRO Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Rare Disease CRO Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rare Disease CRO Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rare Disease CRO Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Rare Disease CRO Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Rare Disease CRO Service Market by Company
Precision for Medicine
Orphan-Reach
Medpace
Parexel
PPD
Worldwide Clinical Trials
AllStripes
LabCorp
Novotech
Syneos Health
Vial
Machaon Diagnostics
Caidya
Simbec Orion
Linical
MMS
Veristat
Celero
Rho
PROMETRIKA
Rare Disease CRO Service Segment by Type
Drug Development Strategy
Clinical Trial Management
Rare Disease CRO Service Segment by Application
Cardiovascular
Neuroscience
Ophthalmology
Others
Rare Disease CRO Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rare Disease CRO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rare Disease CRO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rare Disease CRO Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Rare Disease CRO Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Global Rare Disease CRO Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032
Table 2. Global Rare Disease CRO Service Market Size by Region (2021-2026) & (US$ Million)
Table 3. Global Rare Disease CRO Service Market Share by Region (2021-2026)
Table 4. Global Rare Disease CRO Service Market Size by Region (2027-2032) & (US$ Million)
Table 5. Global Rare Disease CRO Service Market Share by Region (2027-2032)
Table 6. Global Rare Disease CRO Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 7. Global Rare Disease CRO Service Market Size by Type (2021-2026) & (US$ Million)
Table 8. Global Rare Disease CRO Service Market Size Share by Type (2021-2026)
Table 9. Global Rare Disease CRO Service Market Size Forecasted by Type (2027-2032) & (US$ Million)
Table 10. Global Rare Disease CRO Service Market Size Share Forecasted by Type (2027-2032)
Table 11. North America Rare Disease CRO Service Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 12. North America Rare Disease CRO Service Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 13. Europe Rare Disease CRO Service Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 14. Europe Rare Disease CRO Service Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 15. Asia-Pacific Rare Disease CRO Service Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 16. Asia-Pacific Rare Disease CRO Service Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 17. Latin America Rare Disease CRO Service Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 18. Latin America Rare Disease CRO Service Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 19. Middle East and Africa Rare Disease CRO Service Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 20. Middle East and Africa Rare Disease CRO Service Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 21. Global Rare Disease CRO Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 22. Global Rare Disease CRO Service Market Size by Application (2021-2026) & (US$ Million)
Table 23. Global Rare Disease CRO Service Market Size Share by Application (2021-2026)
Table 24. Global Rare Disease CRO Service Market Size Forecasted by Application (2027-2032) & (US$ Million)
Table 25. Global Rare Disease CRO Service Market Size Share Forecasted by Application (2027-2032)
Table 26. North America Rare Disease CRO Service Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 27. North America Rare Disease CRO Service Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 28. Europe Rare Disease CRO Service Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 29. Europe Rare Disease CRO Service Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 30. Asia-Pacific Rare Disease CRO Service Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 31. Asia-Pacific Rare Disease CRO Service Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 32. Latin America Rare Disease CRO Service Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 33. Latin America Rare Disease CRO Service Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 34. Middle East and Africa Rare Disease CRO Service Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 35. Middle East and Africa Rare Disease CRO Service Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 36. Rare Disease CRO Service Industry Trends
Table 37. Rare Disease CRO Service Industry Drivers
Table 38. Rare Disease CRO Service Industry Opportunities and Challenges
Table 39. Rare Disease CRO Service Industry Restraints
Table 40. Global Rare Disease CRO Service Revenue by Company (US$ Million) & (2021-2026)
Table 41. Global Rare Disease CRO Service Revenue Market Share by Company (2021-2026)
Table 42. Global Rare Disease CRO Service Industry Company Ranking, 2024 VS 2025 VS 2026
Table 43. Global Rare Disease CRO Service Key Company Headquarters & Area Served
Table 44. Global Rare Disease CRO Service Company, Product Type & Application
Table 45. Global Rare Disease CRO Service Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Rare Disease CRO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 48. Precision for Medicine Company Information
Table 49. Precision for Medicine Business Overview
Table 50. Precision for Medicine Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 51. Precision for Medicine Rare Disease CRO Service Product Portfolio
Table 52. Precision for Medicine Recent Development
Table 53. Orphan-Reach Company Information
Table 54. Orphan-Reach Business Overview
Table 55. Orphan-Reach Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 56. Orphan-Reach Rare Disease CRO Service Product Portfolio
Table 57. Orphan-Reach Recent Development
Table 58. Medpace Company Information
Table 59. Medpace Business Overview
Table 60. Medpace Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 61. Medpace Rare Disease CRO Service Product Portfolio
Table 62. Medpace Recent Development
Table 63. Parexel Company Information
Table 64. Parexel Business Overview
Table 65. Parexel Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 66. Parexel Rare Disease CRO Service Product Portfolio
Table 67. Parexel Recent Development
Table 68. PPD Company Information
Table 69. PPD Business Overview
Table 70. PPD Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 71. PPD Rare Disease CRO Service Product Portfolio
Table 72. PPD Recent Development
Table 73. Worldwide Clinical Trials Company Information
Table 74. Worldwide Clinical Trials Business Overview
Table 75. Worldwide Clinical Trials Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 76. Worldwide Clinical Trials Rare Disease CRO Service Product Portfolio
Table 77. Worldwide Clinical Trials Recent Development
Table 78. AllStripes Company Information
Table 79. AllStripes Business Overview
Table 80. AllStripes Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 81. AllStripes Rare Disease CRO Service Product Portfolio
Table 82. AllStripes Recent Development
Table 83. LabCorp Company Information
Table 84. LabCorp Business Overview
Table 85. LabCorp Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 86. LabCorp Rare Disease CRO Service Product Portfolio
Table 87. LabCorp Recent Development
Table 88. Novotech Company Information
Table 89. Novotech Business Overview
Table 90. Novotech Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 91. Novotech Rare Disease CRO Service Product Portfolio
Table 92. Novotech Recent Development
Table 93. Syneos Health Company Information
Table 94. Syneos Health Business Overview
Table 95. Syneos Health Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 96. Syneos Health Rare Disease CRO Service Product Portfolio
Table 97. Syneos Health Recent Development
Table 98. Vial Company Information
Table 99. Vial Business Overview
Table 100. Vial Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 101. Vial Rare Disease CRO Service Product Portfolio
Table 102. Vial Recent Development
Table 103. Machaon Diagnostics Company Information
Table 104. Machaon Diagnostics Business Overview
Table 105. Machaon Diagnostics Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 106. Machaon Diagnostics Rare Disease CRO Service Product Portfolio
Table 107. Machaon Diagnostics Recent Development
Table 108. Caidya Company Information
Table 109. Caidya Business Overview
Table 110. Caidya Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 111. Caidya Rare Disease CRO Service Product Portfolio
Table 112. Caidya Recent Development
Table 113. Simbec Orion Company Information
Table 114. Simbec Orion Business Overview
Table 115. Simbec Orion Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 116. Simbec Orion Rare Disease CRO Service Product Portfolio
Table 117. Simbec Orion Recent Development
Table 118. Linical Company Information
Table 119. Linical Business Overview
Table 120. Linical Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 121. Linical Rare Disease CRO Service Product Portfolio
Table 122. Linical Recent Development
Table 123. MMS Company Information
Table 124. MMS Business Overview
Table 125. MMS Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 126. MMS Rare Disease CRO Service Product Portfolio
Table 127. MMS Recent Development
Table 128. Veristat Company Information
Table 129. Veristat Business Overview
Table 130. Veristat Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 131. Veristat Rare Disease CRO Service Product Portfolio
Table 132. Veristat Recent Development
Table 133. Celero Company Information
Table 134. Celero Business Overview
Table 135. Celero Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 136. Celero Rare Disease CRO Service Product Portfolio
Table 137. Celero Recent Development
Table 138. Rho Company Information
Table 139. Rho Business Overview
Table 140. Rho Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 141. Rho Rare Disease CRO Service Product Portfolio
Table 142. Rho Recent Development
Table 143. PROMETRIKA Company Information
Table 144. PROMETRIKA Business Overview
Table 145. PROMETRIKA Rare Disease CRO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 146. PROMETRIKA Rare Disease CRO Service Product Portfolio
Table 147. PROMETRIKA Recent Development
Table 148. North America Rare Disease CRO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 149. North America Rare Disease CRO Service Market Size by Country (2021-2026) & (US$ Million)
Table 150. North America Rare Disease CRO Service Market Share by Country (2021-2026)
Table 151. North America Rare Disease CRO Service Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 152. North America Rare Disease CRO Service Market Share Forecast by Country (2027-2032)
Table 153. Europe Rare Disease CRO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 154. Europe Rare Disease CRO Service Market Size by Country (2021-2026) & (US$ Million)
Table 155. Europe Rare Disease CRO Service Market Share by Country (2021-2026)
Table 156. Europe Rare Disease CRO Service Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 157. Europe Rare Disease CRO Service Market Share Forecast by Country (2027-2032)
Table 158. Asia-Pacific Rare Disease CRO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 159. Asia-Pacific Rare Disease CRO Service Market Size by Country (2021-2026) & (US$ Million)
Table 160. Asia-Pacific Rare Disease CRO Service Market Share by Country (2021-2026)
Table 161. Asia-Pacific Rare Disease CRO Service Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 162. Asia-Pacific Rare Disease CRO Service Market Share Forecast by Country (2027-2032)
Table 163. Latin America Rare Disease CRO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 164. Latin America Rare Disease CRO Service Market Size by Country (2021-2026) & (US$ Million)
Table 165. Latin America Rare Disease CRO Service Market Share by Country (2021-2026)
Table 166. Latin America Rare Disease CRO Service Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 167. Latin America Rare Disease CRO Service Market Share Forecast by Country (2027-2032)
Table 168. Middle East & Africa Rare Disease CRO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 169. Middle East & Africa Rare Disease CRO Service Market Size by Country (2021-2026) & (US$ Million)
Table 170. Middle East & Africa Rare Disease CRO Service Market Share by Country (2021-2026)
Table 171. Middle East & Africa Rare Disease CRO Service Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 172. Middle East & Africa Rare Disease CRO Service Market Share Forecast by Country (2027-2032)
Table 173. Research Programs/Design for This Report
Table 174. Authors List of This Report
Table 175. Secondary Sources
List of Figures
Figure 1.List of Figures
Figure 2. Rare Disease CRO Service Product Image
Figure 3. Global Rare Disease CRO Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 4. Global Rare Disease CRO Service Market Size (2021-2032) & (US$ Million)
Figure 5. Global Rare Disease CRO Service Market Share by Region: 2025 VS 2032
Figure 6. Global Rare Disease CRO Service Market Share by Region (2021-2032)
Figure 7. North America Rare Disease CRO Service Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 8. Europe Rare Disease CRO Service Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 9. Asia-Pacific Rare Disease CRO Service Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 10. Latin America Rare Disease CRO Service Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 11. Middle East & Africa Rare Disease CRO Service Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 12. Drug Development Strategy Image
Figure 13. Global Drug Development Strategy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 14. Clinical Trial Management Image
Figure 15. Global Clinical Trial Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 16. Global Rare Disease CRO Service Market Size Overview by Type (2021-2032) & (US$ Million)
Figure 17. Global Rare Disease CRO Service Market Share by Type 2025 VS 2032
Figure 18. North America Rare Disease CRO Service Market Size Share by Type (2021-2032)
Figure 19. Europe Rare Disease CRO Service Market Size Share by Type (2021-2032)
Figure 20. Asia-Pacific Rare Disease CRO Service Market Size Share by Type (2021-2032)
Figure 21. Latin America Rare Disease CRO Service Market Size Share by Type (2021-2032)
Figure 22. Middle East and Africa Rare Disease CRO Service Market Size Share by Type (2021-2032)
Figure 23. Cardiovascular Image
Figure 24. Global Cardiovascular Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Neuroscience Image
Figure 26. Global Neuroscience Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Ophthalmology Image
Figure 28. Global Ophthalmology Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Others Image
Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Global Rare Disease CRO Service Market Size Overview by Application (2021-2032) & (US$ Million)
Figure 32. Global Rare Disease CRO Service Market Share by Application 2025 VS 2032
Figure 33. North America Rare Disease CRO Service Market Size Share by Application (2021-2032)
Figure 34. Europe Rare Disease CRO Service Market Size Share by Application (2021-2032)
Figure 35. Asia-Pacific Rare Disease CRO Service Market Size Share by Application (2021-2032)
Figure 36. Latin America Rare Disease CRO Service Market Size Share by Application (2021-2032)
Figure 37. Middle East and Africa Rare Disease CRO Service Market Size Share by Application (2021-2032)
Figure 38. Global Top 5 and 10 Rare Disease CRO Service Players Market Share by Revenue in 2025
Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 40. North America Rare Disease CRO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 41. North America Rare Disease CRO Service Market Share by Country: 2021 VS 2025 VS 2032
Figure 42. North America Rare Disease CRO Service Market Share by Country (2021-2032)
Figure 43. Europe Rare Disease CRO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 44. Europe Rare Disease CRO Service Market Share by Country: 2021 VS 2025 VS 2032
Figure 45. Europe Rare Disease CRO Service Market Share by Country (2021-2032)
Figure 46. Asia-Pacific Rare Disease CRO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 47. Asia-Pacific Rare Disease CRO Service Market Share by Country: 2021 VS 2025 VS 2032
Figure 48. Asia-Pacific Rare Disease CRO Service Market Share by Country (2021-2032)
Figure 49. Latin America Rare Disease CRO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 50. Latin America Rare Disease CRO Service Market Share by Country: 2021 VS 2025 VS 2032
Figure 51. Latin America Rare Disease CRO Service Market Share by Country (2021-2032)
Figure 52. Middle East & Africa Rare Disease CRO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 53. Middle East & Africa Rare Disease CRO Service Market Share by Country: 2021 VS 2025 VS 2032
Figure 54. Middle East & Africa Rare Disease CRO Service Market Share by Country (2021-2032)
Figure 55. Years Considered
Figure 56. Research Process
Figure 57. Key Executives Interviewed
Scope & coverage.
Types
- Drug Development Strategy
- Clinical Trial Management
Applications
- Cardiovascular
- Neuroscience
- Ophthalmology
- Others
Companies covered
- Precision for Medicine
- Orphan-Reach
- Medpace
- Parexel
- PPD
- Worldwide Clinical Trials
- AllStripes
- LabCorp
- Novotech
- Syneos Health
- Vial
- Machaon Diagnostics
- Caidya
- Simbec Orion
- Linical
- MMS
- Veristat
- Celero
- Rho
- PROMETRIKA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Rare Disease CRO Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Rare Disease CRO Service Market Size by Region (2021-2032)
- 1.4.1 Global Rare Disease CRO Service Market Size by Region (2021-2026)
- 1.4.2 Global Rare Disease CRO Service Market Size by Region (2027-2032)
- 1.5 Key Regions Rare Disease CRO Service Market Size (2021-2032)
- 1.5.1 North America Rare Disease CRO Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Rare Disease CRO Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Rare Disease CRO Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Rare Disease CRO Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Rare Disease CRO Service Market Size Growth Rate (2021-2032)
2 Rare Disease CRO Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Drug Development Strategy
- 2.1.2 Clinical Trial Management
- 2.2 Global Rare Disease CRO Service Market Size by Type
- 2.2.1 Global Rare Disease CRO Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Rare Disease CRO Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Rare Disease CRO Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Rare Disease CRO Service Market Size by Regions
- 2.3.1 North America Rare Disease CRO Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Rare Disease CRO Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Rare Disease CRO Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Rare Disease CRO Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Rare Disease CRO Service Market Size Breakdown by Type (2021-2026)
3 Rare Disease CRO Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Cardiovascular
- 3.1.2 Neuroscience
- 3.1.3 Ophthalmology
- 3.1.4 Others
- 3.2 Global Rare Disease CRO Service Market Size by Application
- 3.2.1 Global Rare Disease CRO Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Rare Disease CRO Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Rare Disease CRO Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Rare Disease CRO Service Market Size by Regions
- 3.3.1 North America Rare Disease CRO Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Rare Disease CRO Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Rare Disease CRO Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Rare Disease CRO Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Rare Disease CRO Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Rare Disease CRO Service Industry Trends
- 4.2 Rare Disease CRO Service Industry Drivers
- 4.3 Rare Disease CRO Service Industry Opportunities and Challenges
- 4.4 Rare Disease CRO Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Rare Disease CRO Service Revenue (2021-2026)
- 5.2 Global Rare Disease CRO Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Rare Disease CRO Service Key Company Headquarters & Area Served
- 5.4 Global Rare Disease CRO Service Company, Product Type & Application
- 5.5 Global Rare Disease CRO Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Rare Disease CRO Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Rare Disease CRO Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Rare Disease CRO Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Precision for Medicine
- 6.1.1 Precision for Medicine Company Information
- 6.1.2 Precision for Medicine Business Overview
- 6.1.3 Precision for Medicine Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Precision for Medicine Rare Disease CRO Service Product Portfolio
- 6.1.5 Precision for Medicine Recent Developments
- 6.2 Orphan-Reach
- 6.2.1 Orphan-Reach Company Information
- 6.2.2 Orphan-Reach Business Overview
- 6.2.3 Orphan-Reach Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Orphan-Reach Rare Disease CRO Service Product Portfolio
- 6.2.5 Orphan-Reach Recent Developments
- 6.3 Medpace
- 6.3.1 Medpace Company Information
- 6.3.2 Medpace Business Overview
- 6.3.3 Medpace Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Medpace Rare Disease CRO Service Product Portfolio
- 6.3.5 Medpace Recent Developments
- 6.4 Parexel
- 6.4.1 Parexel Company Information
- 6.4.2 Parexel Business Overview
- 6.4.3 Parexel Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Parexel Rare Disease CRO Service Product Portfolio
- 6.4.5 Parexel Recent Developments
- 6.5 PPD
- 6.5.1 PPD Company Information
- 6.5.2 PPD Business Overview
- 6.5.3 PPD Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 PPD Rare Disease CRO Service Product Portfolio
- 6.5.5 PPD Recent Developments
- 6.6 Worldwide Clinical Trials
- 6.6.1 Worldwide Clinical Trials Company Information
- 6.6.2 Worldwide Clinical Trials Business Overview
- 6.6.3 Worldwide Clinical Trials Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Worldwide Clinical Trials Rare Disease CRO Service Product Portfolio
- 6.6.5 Worldwide Clinical Trials Recent Developments
- 6.7 AllStripes
- 6.7.1 AllStripes Company Information
- 6.7.2 AllStripes Business Overview
- 6.7.3 AllStripes Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 AllStripes Rare Disease CRO Service Product Portfolio
- 6.7.5 AllStripes Recent Developments
- 6.8 LabCorp
- 6.8.1 LabCorp Company Information
- 6.8.2 LabCorp Business Overview
- 6.8.3 LabCorp Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 LabCorp Rare Disease CRO Service Product Portfolio
- 6.8.5 LabCorp Recent Developments
- 6.9 Novotech
- 6.9.1 Novotech Company Information
- 6.9.2 Novotech Business Overview
- 6.9.3 Novotech Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Novotech Rare Disease CRO Service Product Portfolio
- 6.9.5 Novotech Recent Developments
- 6.10 Syneos Health
- 6.10.1 Syneos Health Company Information
- 6.10.2 Syneos Health Business Overview
- 6.10.3 Syneos Health Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Syneos Health Rare Disease CRO Service Product Portfolio
- 6.10.5 Syneos Health Recent Developments
- 6.11 Vial
- 6.11.1 Vial Company Information
- 6.11.2 Vial Business Overview
- 6.11.3 Vial Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Vial Rare Disease CRO Service Product Portfolio
- 6.11.5 Vial Recent Developments
- 6.12 Machaon Diagnostics
- 6.12.1 Machaon Diagnostics Company Information
- 6.12.2 Machaon Diagnostics Business Overview
- 6.12.3 Machaon Diagnostics Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Machaon Diagnostics Rare Disease CRO Service Product Portfolio
- 6.12.5 Machaon Diagnostics Recent Developments
- 6.13 Caidya
- 6.13.1 Caidya Company Information
- 6.13.2 Caidya Business Overview
- 6.13.3 Caidya Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Caidya Rare Disease CRO Service Product Portfolio
- 6.13.5 Caidya Recent Developments
- 6.14 Simbec Orion
- 6.14.1 Simbec Orion Company Information
- 6.14.2 Simbec Orion Business Overview
- 6.14.3 Simbec Orion Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Simbec Orion Rare Disease CRO Service Product Portfolio
- 6.14.5 Simbec Orion Recent Developments
- 6.15 Linical
- 6.15.1 Linical Company Information
- 6.15.2 Linical Business Overview
- 6.15.3 Linical Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Linical Rare Disease CRO Service Product Portfolio
- 6.15.5 Linical Recent Developments
- 6.16 MMS
- 6.16.1 MMS Company Information
- 6.16.2 MMS Business Overview
- 6.16.3 MMS Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 MMS Rare Disease CRO Service Product Portfolio
- 6.16.5 MMS Recent Developments
- 6.17 Veristat
- 6.17.1 Veristat Company Information
- 6.17.2 Veristat Business Overview
- 6.17.3 Veristat Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Veristat Rare Disease CRO Service Product Portfolio
- 6.17.5 Veristat Recent Developments
- 6.18 Celero
- 6.18.1 Celero Company Information
- 6.18.2 Celero Business Overview
- 6.18.3 Celero Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Celero Rare Disease CRO Service Product Portfolio
- 6.18.5 Celero Recent Developments
- 6.19 Rho
- 6.19.1 Rho Company Information
- 6.19.2 Rho Business Overview
- 6.19.3 Rho Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Rho Rare Disease CRO Service Product Portfolio
- 6.19.5 Rho Recent Developments
- 6.20 PROMETRIKA
- 6.20.1 PROMETRIKA Company Information
- 6.20.2 PROMETRIKA Business Overview
- 6.20.3 PROMETRIKA Rare Disease CRO Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 PROMETRIKA Rare Disease CRO Service Product Portfolio
- 6.20.5 PROMETRIKA Recent Developments
7 North America
- 7.1 North America Rare Disease CRO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Rare Disease CRO Service Market Size by Country (2021-2026)
- 7.3 North America Rare Disease CRO Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Rare Disease CRO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Rare Disease CRO Service Market Size by Country (2021-2026)
- 8.3 Europe Rare Disease CRO Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Rare Disease CRO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Rare Disease CRO Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Rare Disease CRO Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Rare Disease CRO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Rare Disease CRO Service Market Size by Country (2021-2026)
- 10.3 South America Rare Disease CRO Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Rare Disease CRO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Rare Disease CRO Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Rare Disease CRO Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,450USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst